ANALYSIS OF FACTORS RELATED TO THE TOLERABILITY OF LENVATINIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CONDITIONS: A MULTICENTER STUDY

被引：0

作者：

Taniki, Nobuhito ^{[1
]}

Nakamoto, Nobuhiro ^{[1
]}

Chu, Po-Sung ^{[1
]}

Shiba, Shunsuke ^{[2
]}

Tahara, Toshiyuki ^{[2
]}

Komatsu, Hirokazu ^{[3
]}

Okamura, Yukishige ^{[4
]}

Ojiro, Keisuke ^{[5
]}

Kikuchi, Masahiro ^{[6
]}

Aoki, Yu ^{[7
]}

Yamaguchi, Akihiro ^{[8
]}

Usui, Shingo ^{[8
]}

Kanai, Takanori ^{[1
]}

机构：

[1] Keio Univ, Dept Gastroenterol & Hepatol, Sch Med, Keio, Japan

[2] Saiseikai Utsunomiya Hosp, Utsunomiya, Tochigi, Japan

[3] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan

[4] Sano Kosei Gen Hosp, Sano, Japan

[5] Ichikawa Gen Hosp, Tokyo Dent Coll, Ichikawa, Japan

[6] Natl Hosp Org Tokyo Med Ctr, Tokyo, Japan

[7] Saiseikai Cent Hosp, Tokyo, Japan

[8] Natl Hosp Org Saitama Natl Hosp, Dept Gastroenterol & Hepatol, Saitama, Japan

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1141

引用

页码：689A / 689A

页数：1

共 50 条

[1] Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
Hiraoka, Atsushi
Kumada, Takashi
Kariyama, Kazuya
Takaguchi, Koichi
Atsukawa, Masanori
Itobayashi, Ei
Tsuji, Kunihiko
Tajiri, Kazuto
Hirooka, Masashi
Shimada, Noritomo
Shibata, Hiroshi
Ishikawa, Toru
Ochi, Hironori
Tada, Toshifumi
Toyoda, Hidenori
Nouso, Kazuhiro
Tsutsui, Akemi
Itokawa, Norio
Imai, Michitaka
Joko, Kouji
Hiasa, Yoichi
Michitaka, Kojiro
[J]. CANCER MEDICINE, 2019, 8 (01): : 137 - 146
[2] LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD PRACTICE - MULTICENTER ANALYSIS OF PROGNOSTIC FACTORS
Hiraoka, Atsushi
Kumada, Takashi
Atsukawa, Masanori
Hirooka, Masashi
Ishikawa, Toru
Kunihiko, Tsuji
Takaguchi, Koichi
Kariyama, Kazuya
Itobayashi, Ei
Tajiri, Kazuto
Shimada, Noritomo
Shibata, Hiroshi
Ochi, Hironori
Tada, Toshifumi
Toyoda, Hidenori
Nouso, Kazuhiro
Tsutsui, Akemi, Sr.
Nagano, Takuya
Itokawa, Norio
Hayama, Korenobu
Imai, Michitaka
Joko, Kouji
Koizumi, Yohei
Hiasa, Yoichi
Michitaka, Kojiro
Kudo, Masatoshi
[J]. HEPATOLOGY, 2019, 70 : 217A - 218A
[3] Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis
Hiraoka, Atsushi
Kumada, Takashi
Atsukawa, Masanori
Hirooka, Masashi
Tsuji, Kunihiko
Ishikawa, Toru
Takaguchi, Koichi
Kariyama, Kazuya
Itobayashi, Ei
Tajiri, Kazuto
Shimada, Noritomo
Shibata, Hiroshi
Ochi, Hironori
Tada, Toshifumi
Toyoda, Hidenori
Nouso, Kazuhiro
Tsutsui, Akemi
Nagano, Takuya
Itokawa, Norio
Hayama, Korenobu
Imai, Michitaka
Joko, Kouji
Koizumi, Yohei
Hiasa, Yoichi
Michitaka, Kojiro
Kudo, Masatoshi
[J]. CANCER MEDICINE, 2019, 8 (08): : 3719 - 3728
[4] The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
Tsuchiya, Kaoru
Kurosaki, Masayuki
Sakamoto, Azusa
Marusawa, Hiroyuki
Kojima, Yuji
Hasebe, Chitomi
Arai, Hirotaka
Joko, Kouji
Kondo, Masahiko
Tsuji, Keiji
Sohda, Tetsuro
Kimura, Hiroyuki
Ogawa, Chikara
Uchida, Yasushi
Wada, Shuichi
Kobashi, Haruhiko
Furuta, Koichiro
Shigeno, Masaya
Kusakabe, Atsunori
Akahane, Takehiro
Narita, Ryoichi
Yoshida, Hideo
Mitsuda, Akeri
Ide, Yasushi
Matsushita, Tomomichi
Izumi, Namiki
[J]. CANCERS, 2021, 13 (11)
[5] Real-world safety and tolerability data for lenvatinib use in unresectable hepatocellular cancer
Celermajer, Y.
Prince, D.
Stratton, E.
Davidson, S.
Majumdar, A.
Mccaughan, G.
Levy, M.
Strasser, S.
Liu, K.
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 42 - 43
[6] REAL-WORLD SAFETY AND TOLERABILITY DATA FOR LENVATINIB USE IN UNRESECTABLE HEPATOCELLULAR CANCER
Celermajer, Yael
Prince, David S.
Stratton, Elisabeth
Davidson, Scott
Majumdar, Avik
McCaughan, Geoffrey W.
Levy, Miriam T.
Strasser, Simone I.
Liu, Ken
[J]. HEPATOLOGY, 2020, 72 : 704A - 704A
[7] Multicenter, real-world experience with lenvatinib for patients with advanced hepatocellular carcinoma in Japan
Sho, Takuya
Suda, Goki
Ogawa, Koji
Nakai, Masato
Morikawa, Kenichi
Sakamoto., Naoya
[J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
[8] Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA
Singal, Amit G.
Nagar, Saurabh P.
Hitchens, Abby
Davis, Keith L.
Iyer, Shrividya
[J]. FUTURE ONCOLOGY, 2021, 17 (21) : 2759 - 2768
[9] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
Welland, Sabrina
Leyh, Catherine
Finkelmeier, Fabian
Jefremow, Andre
Shmanko, Kateryna
Gonzalez-Carmona, Maria A.
Kandulski, Arne
Jeliazkova, Petia
Best, Jan
Fruendt, Thorben W.
Djanani, Angela
Pangerl, Maria
Maieron, Andreas
Greil, Richard
Fricke, Christina
Sookthai, Disorn
Guenther, Rainer
Schmiderer, Andreas
Wege, Henning
Venerito, Marino
Ehmer, Ursula
Mueller, Martina
Strassburg, Christian P.
Weinmann, Arndt
Siebler, Jurgen
Waidmann, Oliver
Lange, Christian M.
Saborowski, Anna
Vogel, Arndt
[J]. LIVER CANCER, 2022, 11 (03) : 219 - 232
[10] Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
Kurvi Patwala
David Stephen Prince
Yael Celermajer
Waafiqa Alam
Eldho Paul
Simone Irene Strasser
Geoffrey William McCaughan
Paul Gow
Siddharth Sood
Elise Murphy
Stuart Roberts
Elliot Freeman
Elizabeth Stratton
Scott Anthony Davison
Miriam Tania Levy
McCawley Clark-Dickson
Vi Nguyen
Sally Bell
Amanda Nicoll
Ashley Bloom
Alice Unah Lee
Marno Ryan
Jessica Howell
Zina Valaydon
Alexandra Mack
Ken Liu
Anouk Dev
[J]. Hepatology International, 2022, 16 : 1170 - 1178

← 1 2 3 4 5 →